UC San Diego Researchers Find Promise in Non-Human Sialic Acid Antibodies
Researchers at the University of California, San Diego School of Medicine say antibodies to a non-human sugar molecule commonly found in people may be useful as a future biomarker for predicting cancer risk, for diagnosing cancer cases early and, in sufficient concentration, used as a treatment for suppressing tumor growth…. Read the full story from the UCSD Newsroom
Dr. Richard Schwab and Dr. Ajit Varki (pictured above left), led the study, which was a multicenter collaboration that included the departments of Medicine and of Cellular and Molecular Medicine, Moores Cancer Center, and the Glycobiology Research and Training Center at UC San Diego.
Richard Schwab, MD, is Assistant Professor of Medicine in the Division of Hematology-Oncology. Ajit Varki, MD, is Distinguished Professor of Medicine and Cellular and Molecular Medicine, Co-Director of the Glycobiology Research and Training Center, and Co-Director of the UCSD/Salk Center for Academic Research and Training in Anthropogeny. Read the abstract of the published study in Cancer Research.